lamotrigine, Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: lamotrigine
BRAND NAME: Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR
DRUG CLASS AND MECHANISM: Lamotrigine is an oral drug that is used primarily for treating seizures. It is chemically unrelated to other anti-seizure drugs. The precise mechanism by which lamotrigine exerts its anti-seizure action is not known. The FDA approved lamotrigine in December 1974.
GENERIC AVAILABLE: Yes
STORAGE: Tablets should be stored at room temperature, between 15-30 C (59-86 F).
PRESCRIBED FOR: Lamotrigine is used in combination with other anti-seizure drugs for the treatment of partial seizures, tonic-clonic seizures, and seizures of Lennox-Gastaut syndrome. It also is used alone for treating partial seizures in patients 16 years and older when converting from other anti-epileptic drugs. Lamotrigine also is used for preventing mood episodes in individuals 18 years or older with bipolar disorder.
DOSING: The dose of immediate release lamotrigine for seizures in patients not taking valproic acid (Depakote, Depakote ER, Depakene, Depacon, Stavzor), but taking seizure medications that reduce lamotrigine blood levels (for example, phenobarbitol, phenytoin [Dilantin, Dilantin-125], carbamazepine [Tegretol], primidone) is 50 mg once daily for two weeks, followed by 100 mg daily given in two divided doses for two weeks. Thereafter, the dose is increased by 100 mg daily every 1-2 weeks up to the usual maintenance dose of 300 to 500 mg daily given as a divided dose.
In patients who are taking valproic acid in which it increases blood levels of lamotrigine, the initial dose of lamotrigine is 25 mg every other day for two weeks, then 25 mg once daily for two weeks. After 4 weeks the dose is slowly increased by 25 to 50 mg per day every one to two weeks until a dose of 100 to 400 mg once daily or divided twice daily is reached. The maintenance dose when using extended release tablets is 200 to 600 mg once daily.
The target dose for treating bipolar disorder is 100 to 400 mg daily.
DRUG INTERACTIONS: Lamotrigine can interact with valproic acid. When lamotrigine is initiated in patients already receiving valproic acid, the blood concentrations of valproic acid can decrease over a 3-week period. This may result in loss of seizure control. Valproic acid increases lamotrigine levels. The risk of severe skin rash may be increased by combining lamotrigine with valproic acid. There may be a higher incidence of dizziness, double vision, and blurred vision in patients receiving carbamazepine together with lamotrigine. The mechanism of this interaction is unclear.
Estrogen containing oral contraceptives, phenobarbitol, primidone, phenytoin, and rifampin reduce the blood levels of lamotrigine by 40%-50% by increasing the breakdown of lamotrigine in the liver. This may result in reduced efficacy if the dose of lamotrigine is not adjusted.
PREGNANCY: Use of lamotrigine during pregnancy has not been adequately evaluated.
NURSING MOTHERS: Lamotrigine is secreted into human breast milk. Because the effects on the infant are unknown, breastfeeding while taking lamotrigine is not recommended.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index